Most recent by Sara E. Smith
New procedure uses amniomembrane for eye reconstruction
SALZBURG, Germany — The use of preserved amniotic membrane can provide a favorable extracellular matrix substrate for epithelial migration and adhesion. Amniotic membrane can suppress inflammation and promote epithelial healing.
Rescula gets FDA approval as concomitant glaucoma therapy
WASHINGTON — Rescula (unoprostone isopropyl ophthalmic solution 0.15%; CIBA Vision) has received U.S. Food and Drug Administration (FDA) approval for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are intolerant of other IOP lowering medications or insufficiently responsive to another IOP lowering medication.
Role of antioxidants in slowing progression of AMD still subject of debate
Exactly why age-related macular degeneration (AMD) develops is not known, and no treatment thus far has been steadily effective. Disputed theories suggest that supplemental vitamins, minerals and antioxidants may slow the progression of the dry form of AMD and stabilize the eye.
MIC is only part of overall effectiveness
Attempts to prevent and control infection can be challenging and costly to practitioners and patients. Clinicians must quantify the effectiveness of anti-infective agents on different organisms to help determine the clinical outcomes of the chosen therapy.